Biocon arm secures USFDA approval for Everolimus Tablets for prophylaxis of organ rejection in adult patients Ruchika Sharma11 April 2025 12:30 PM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval...
Natco Pharma gets approval for Everolimus tablets for Oral Suspension for subependymal giant cell astrocytoma Ruchika Sharma30 Jan 2025 11:30 AM ISTHyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug Administration...
Biocon launches cancer drug Everolimus in US Ruchika Sharma4 Oct 2021 5:15 PM ISTBengaluru: Global Biopharma company, Biocon Ltd, today announced the expansion of its Generic Formulations portfolio with the launch...
Natco Pharma marketing partner launches generic version of Afinitor in US Ruchika Sharma2 Oct 2021 10:30 AM ISTHyderabad: Drugmaker, Natco Pharma Limited, has recently announced that the company's marketing partner Breckenridge Pharmaceutical, Inc., US has...
Natco Pharma marketing partner gets USFDA approval for Everolimus tablets Ruchika Sharma23 May 2021 11:30 AM ISTHyderabad: Drugmaker, Natco Pharma Limited, has recently announced that the company's marketing partner, Breckenridge Pharmaceutical Inc. (BPI), has...
Natco marketing partner Breckenridge Pharma gets USFDA nod for cancer drug Everolimus Ruchika Sharma8 March 2021 2:55 PM ISTHyderabad: Pharma major, Natco Pharma Limited, today announced that the company's marketing partner, Breckenridge Pharmaceutical Inc. (BPI), has...
